The c-Cbl proto-oncogene acts as an E3 ubiquitin ligase via its RING ®nger domain to negatively regulate activated cellular signal transduction pathways. We have identi®ed an aberrant Cbl-protein of approximately 95 kDa, which we have called p95Cbl, from the murine reticulum sarcoma cell-line, J-774. Cloning of the p95Cbl cDNA revealed that it contains a deletion resulting in the loss of 111 amino acids, eliminating two critical tyrosine residues in the linker region as well as the entire RING ®nger domain. p95Cbl displays a propensity for its interaction with the Src-family kinase Hck over cellular Cbl expressed in the same cells. Like its wildtype counterpart, p95Cbl is inducibly tyrosine phosphorylated in response to Fcg receptor engagement on hematopoietic cells, however this phosphorylation is sustained beyond that of cellular Cbl. NIH3T3 ®bro-blasts stably expressing p95Cbl acquire the typical refractile morphology associated with cellular transformation and form colonies in a focus-formation assay. The exogenously expressed mutant protein is constitutively phosphorylated in ®broblasts and partitions into the particulate fraction of cells, while cellular Cbl is exclusively cytoplasmic. p95Cbl is a novel, oncogenic mutant of the c-Cbl proto-oncogene, which might act in a dominant negative fashion to prolong normal cellular signaling responses by interfering with the downregulation of activated signaling complexes through cCbl.
Introduction c-Cbl is the cellular homologue of the v-Cbl oncogene and was ®rst cloned from a recombinant murine retrovirus that causes pro-and pre-B-cell lymphomas and myelogenous leukemias in mice (Langdon et al., 1989a) . The 120 kDa c-Cbl proto-oncogene product is a prominent substrate of receptor and cytoplasmic tyrosine kinases and is rapidly phosphorylated in response to stimulation of a variety of receptors, including growth factor, antigen, cytokine and integrin receptors (reviewed in Liu and Altman, 1998; ). Due to the lack of an apparent enzymatic activity, the multi-domain Cbl protein was originally thought to act as an adaptor protein aiding in the assembly of active signaling complexes downstream of these receptors. This was in contrast to genetic data from C. elegans, Drosophila and mice, which had implicated Cbl in the negative regulation of tyrosine kinase signaling Meisner et al., 1997; Naramura et al., 1998) . The mechanism underlying this negative regulatory function, however, remained unclear until the recent discovery that Cbl possesses E3 ubiquitin-ligase activity and can mediate the ubiquitination and subsequent proteasome-mediated degradation of activated receptors and cytoplasmic signaling proteins (Joazeiro et al., 1999; Levkowitz et al., 1999; Howlett and Robbins, 2002) . This activity is mediated by Cbl's RING ®nger domain, which is capable of recruiting E2 ubiquitin conjugating enzymes into active signaling complexes (Joazeiro et al., 1999; Levkowitz et al., 1999; Yokouchi et al., 1999) .
Apart from the RING ®nger domain, several protein ± protein interaction domains in Cbl are instrumental in conferring speci®city to its ubiquitination activity. The Cbl N-terminus is comprised of a tyrosine-kinase binding (TKB) domain (Meng et al., 1999) and mediates its binding to phosphorylated targets, such as the PDGF and EGF receptors (Bonita et al., 1997; Lill et al., 2000; Miyake et al., 1999) and the cytoplasmic tyrosine kinases Syk, Zap70 and Src (Lupher et al., 1996 (Lupher et al., , 1998 Sanjay et al., 2001 ). An intact TKB and RING ®nger domain are crucial for Cbl's ubiquitination activity towards its targets, and are conserved in the Drosophila and C. elegans Cbl orthologues (Meisner et al., 1997; Yoon et al., 1995) as well as the other two subsequently identi®ed mammalian Cbl-proteins, Cbl-b and Cbl3 (Keane et al., 1995 (Keane et al., , 1999 . Three key tyrosine residues present in the Cbl Cterminus provide docking sites for SH2 domaincontaining proteins when phosphorylated by kinases of the Src-and Syk-family (Feshchenko et al., 1998) . In addition, the presence of several proline-rich motifs allows for the constitutive association of Cbl with SH3 domain-containing signaling molecules, such as the adaptor proteins Grb2 and Nck, and the Src-family protein tyrosine kinases Fyn and Src (Donovan et al., 1994; Fukazawa et al., 1995; Odai et al., 1995; Panchamoorthy et al., 1996; Rivero-Lezcano et al., 1994) .
The v-Cbl oncogene product is generated by the introduction of a stop-codon, which results in the expression of a truncated protein only retaining the TKB domain, while the C-terminal 2/3 of the fulllength protein are eliminated (Blake et al., 1991) . A second oncogenic Cbl-mutant was cloned from the mouse 70Z/3 pre-B-cell lymphoma line, hence called 70Z Cbl (Blake et al., 1991) . It contains a 17aa deletion (aa 366 ± 385) removing a large portion of the linker region as well as the ®rst cysteine residue in the RING ®nger. Following the realization that the Cbl-RING ®nger is essential for Cbl's negative regulatory function, it was widely assumed that the mutations in this region were responsible for rendering these mutant proteins oncogenic. However, deletion of two single tyrosines, 368 Y or 371 Y, in the linker region that connects the TKB domain to the RING ®nger is sucient to generate potently transforming proteins, whereas disruption of Cbl's ubiquitination function, while probably facilitating transformation, is not sucient to unleash its oncogenic potential (Andoniou et al., 1994; .
During our analysis of c-Cbl function in various hematopoietic cell lines, we identi®ed an aberrant Cbl protein in the murine reticulum cell sarcoma, J-774 . The mutant allele encodes for an approximately 95 kDa Cbl protein, which we will subsequently refer to as p95Cbl. p95Cbl was generated by an internal 111 amino-acid deletion, which results in the loss of the entire RING ®nger and surrounding sequence. p95Cbl participates in at least some of the same signaling pathways in J-774 cells as its wildtype c-Cbl counterpart and displays enhanced tyrosine phosphorylation levels in both quiescent and activated cells. In this study we describe the cloning and biochemical characterization of this aberrant Cbl protein.
Results
An aberrant isoform of the proto-oncogene Cbl is expressed in the murine macrophage cell line, J-774
Using a monoclonal antibody speci®c for the 120 kDa c-Cbl protein to detect Cbl in cell-free lysates of various hematopoietic cell lines, we observed an approximately 95 kDa protein in the murine reticulum cell sarcoma line, J-774 (Figure 1a) , henceforth referred to as p95Cbl. Both, the wildtype 120 kDa and the aberrant 95 kDa protein were present in roughly equal amounts in J-774 cells on Western blot. The 95 kDa protein could be immunoprecipitated with either a monoclonal or a polyclonal antibody raised against the carboxyterminal 14 amino acids (aa 892 ± 906) of the Cbl proto-oncogene product. Both these antibodies as well as a second monoclonal antibody raised to a dierent epitope on Cbl (aa 595 ± 810) also recognized p95Cbl on Western blot (data not shown), suggesting that the mutation resulting in the generation of this aberrant Cbl isoform is not located within these regions. Antisera speci®c for the related Cbl-b protein, which has an approximate molecular weight of 108 kDa, did not react with the 95 kDa protein we observed in J-774 cells con®rming that p95Cbl is not a cbl-b gene product.
To further characterize the biochemical properties of this aberrant Cbl protein, we wanted to determine its subcellular localization. J-774 cells were homogenized in hypotonic lysis buer and fractionated by highspeed centrifugation into the particulate fraction, which is enriched for membranes and the cytosol as described in Materials and methods. The pellet was resuspended in detergent lysis buer and Cbl proteins were immunoprecipitated from the cytosolic and membrane-enriched fractions. The 95 kDa Cbl protein could only be detected in the membrane-enriched fraction, while the 120 kDa c-Cbl protein was present After dilution in 1% NP40 lysis buer, Cbl proteins were immunoprecipitated from the reactions, separated by SDS ± PAGE and visualized by Western blot using an a-Cbl mAb. Molecular weight (MWT) markers are indicated to the left into both, the cytosolic and the particulate fraction ( Figure 1b ).
Since we were also able to detect the 95 kDa protein when the cells were lysed directly in SDS sample buer, we thought it unlikely that it was a proteolytic degradation product of c-Cbl. To further con®rm that the novel Cbl isoform we detected was not a result of protease activity we performed in vitro translation reactions with RNA isolated from J-774 or U937 cells. Cbl-proteins were immunoprecipitated from the in vitro translation reactions and detected by Western blot with a Cbl-speci®c monoclonal antibody. Similar to what we had previously observed in detergent lysates from J-774 cells (Figure 1a) , the 120 and 95 kDa Cbl proteins were present in close to the same amounts in the reactions using J-774 RNA, whereas the smaller form was absent when RNA from U937 cells was used as the starting material ( Figure 1c ). It is of interest to note that Kuwae et al. (2001) recently reported the presence of an approximately 100 kDa, tyrosine phosphorylated Cbl-reactive protein in J-774 macrophages, which likely corresponds to the aberrant 95 kDa Cbl protein we have observed in these cells. This indicates the presence of a primary transcript encoding for a 95 kDa Cbl protein in J-774 cells.
p95Cbl interacts with the Src-family kinase Hck
We have previously shown that wildtype Cbl interacts with various GST-fusion constructs of the Src-family tyrosine kinase Hck in pulldown assays in cell-free detergent extracts of hematopoietic cells (Howlett et al., 1999) . To determine whether p95Cbl shows similar characteristics in its interaction with these constructs, we performed pulldown assays in detergent lysates from quiescent Raw264.7 and J-774 cells (Figure 2a ). The lysates were incubated either with GST alone, or GST-Hck fusion constructs encompassing the unique, the SH2 and the SH3 domains in isolation or the SH3/ SH2 and the unique/SH3/SH2 domains in combination. Following incubation with the individual constructs immobilized on glutathione agarose beads, the beads were washed extensively in lysis buer, separated by SDS ± PAGE and the corresponding Western blot was probed with an a-Cbl monoclonal antibody. In concordance with what we have previously shown (Howlett et al., 1999) , the wildtype Cbl protein interacted with any of the GST-Hck fusion proteins containing the SH2 domain (GST-Hck-SH2, -SH3/SH2 and -unique/SH3/SH2) in pulldown assays from lysates of Raw264.7 cells (Figure 2a , left panel). This pattern was mimicked by p95Cbl in pulldown assays performed in J-774 cell lysates. However, in the presence of the 95 kDa Cbl protein less wildtype Cbl was detected in the pulldowns as compared to p95Cbl ( Figure 2a , right panel) in spite of the fact that both proteins were present at approximately equal levels in J-774 cells ( Figure 1a) . In both cases, the GST-fusion construct encompassing the unique/SH3/SH2 domains of Hck displayed the most robust interaction with the Cbl proteins. Cbl did not associate with the GST moiety on its own, thus indicating that the observed interactions are not due to non-speci®c association of the Cbl proteins with the carrier. We were not able to observe an interaction between the GST-Hck-SH3 domain on its own and either of the Cbl proteins (this study and Howlett et al., 1999) , which was in concordance with a previous report (Anderson et al., 1997) , but contrasted with a recent paper by Scholz et al. (2000) . The fusion protein we used in this report encompassed amino acids 87 ± 137 of human p61Hck and lacks a few amino acids on either end of the Hck-SH3 domain as assessed by X-ray crystallographic and NMR studies (Horita et al., 1998; Sicheri et al., 1997) . It is possible that these amino acids are critically involved in the association of Hck and Cbl and/or for maintaining the proper structure of the SH3 domain and warrants further studies. A similar pattern was observed when the pulldown assays were carried out in lysates from cells that had been stimulated through their Fcg receptors prior to lysis (data not shown), a stimulus known to involve the Src-family kinase Hck (Durden et al., 1995; Suzuki et al., 2000; Wang et al., 1994) and to result in the phosphorylation of Cbl (Marcilla et al., 1995; Tanaka et al., 1995) . More Cbl protein was detected in pulldown assays performed in stimulated cell lysates, suggesting that phosphorylation Cbl competes with wildtype Cbl for binding to GST-Hck fusion proteins. Pulldown assays with GST alone or GST-Hck fusion proteins encompassing the various domains of Hck separately or in combination were performed in cell-free detergent lysates prepared from Raw264.7 or J-774 cells. Hck-interacting proteins were separated by SDS ± PAGE and probed for Cbl by Western blotting with an a-Cbl mAb (7G10). (b) The interaction between Hck and Cbl is direct. Cbl proteins were immunoprecipitated from Raw264.7 or J-774 detergent lysates and separated by SDS ± PAGE. The corresponding blots were incubated with 20 mg/ ml GST alone or the GST-Hck-unique/SH3/SH2 fusion construct. The bound GST-fusion proteins were detected with an a-GST pAb. The GST-Far Western blot was reported with a Cbl mAb of Cbl favors its interaction with Src-family kinases. The above data indicates that much like cellular Cbl, p95Cbl is a potential substrate of Src-family kinases, including Hck in the signaling responses of J-774 cells.
To determine whether the interaction between p95Cbl and Hck was direct as is the case for p120Cbl and Hck (Howlett et al., 1999) , or required the presence of additional`bridging' proteins, we immunoprecipitated Cbl from Raw264.7 and J-774 cell lysates for Far Western analysis. The proteins were separated by SDS ± PAGE and the corresponding Western blots were overlayed with either the GST protein on its own or the GST-Hck-unique/SH3/SH2 fusion protein. The GST-fusion constructs bound to the immunoprecipitated Cbl proteins on the membranes were detected with a-GST polyclonal antiserum ( Figure 2b, left panel) . The Hck-construct associated with both, the wildtype as well as the 95 kDa Cbl protein, while the GST control could not be detected on the membranes, which suggests a direct and speci®c interaction between Hck and both Cbl forms. The GST Far-Western blot was reprobed with a Cbl-speci®c monoclonal antibody to con®rm that the bands visualized by Far Western blotting corresponded to the position of the Cbl proteins on the blot (Figure 2b , right panel).
p95Cbl is a major tyrosine phosphorylated substrate in response to Fcg receptor crosslinking We and others have previously shown that the 120 kDa c-Cbl protein is a major target of tyrosine phosphorylation upon Fcg receptor crosslinking on both human and murine hematopoietic cells (Durden et al., 1995; Howlett et al., 1999) . J-774 cells exhibit cytological, adherent and phagocytic properties of macrophages and express Fcg receptors on their cell surface (Kaplan and Morland, 1978; Ralph and Nakoinz, 1975) . In order to evaluate whether the 95 kDa Cbl protein present in J-774 cells was also an active component of Fcg receptor signaling, Raw264.7 and J-774 cells were incubated with primary mouse IgG antibody either alone (0 18 ) or followed by crosslinking with a secondary antibody on the cell surface. As seen in Figure 3a , an increase in the amount of tyrosine phosphorylated proteins was observed in both J-774 and Raw264.7 cells, which reached a maximum at approximately 5 ± 15 min and returned to baseline levels by 30 min after stimulation (Figure 3a) . The major tyrosine phosphorylated protein induced in Raw264.7 cells was a protein of 120 kDa molecular weight, while the 95 kDa protein was the major substrate in J-774 cells (Figure 3a) . When Cbl was immunoprecipitated from these lysates, it was apparent after detection with a monoclonal anti-phosphotyrosine antibody that p95Cbl phosphorylation was increased as compared to c-Cbl in J-774 cells. Furthermore, while cCbl phosphorylation was transient and returned to basal levels by 30 min of Fcg receptor crosslinking, p95Cbl phosphorylation was sustained up to 60 min of receptor engagement (Figure 3b, upper panel) . Reprobing of the membrane with a Cbl-speci®c polyclonal antibody con®rmed the presence of equal amounts of Cbl proteins in the individual lanes (Figure 3b, lower  panel) . These results identify p95Cbl as a primary target of tyrosine phosphorylation in J-774 cells upon Fcg receptor stimulation.
The p95Cbl protein is the result of a 111 aa internal deletion
To date, two naturally occurring mutant isoforms of Cbl with transforming ability have been identi®ed, vCbl and 70Z Cbl. v-Cbl is generated by a mutation, which introduces a stop-codon that results in the expression of a truncated version of the Cbl protein encompassing the N-terminal 355 amino acids ( Figure  4b ). 70Z Cbl bears a 17 amino acid deletion in the linker region connecting the Cbl-SH2 domain and the RING ®nger domain (Figure 4b ) and is the product of an aberrant splice event caused by a splice acceptor site mutation. In order to determine the mutation leading Cbl tyrosine phosphorylation is enhanced after Fcg receptor stimulation. Cbl proteins were immunoprecipitated from 350 mg of the above lysates, separated by SDS ± PAGE and tyrosine phosphorylated Cbl was detected with the phosphotyrosine-speci®c mAb 4G10 (b, upper panel). To con®rm equal protein loading, the 4G10 blot was reprobed with an a-Cbl pAb (b, lower panel). MWT markers are shown to the left to the formation of the mutant p95Cbl form we cloned the corresponding cDNA from J-774 cells using an RT ± PCR based approach. RNA isolated from J-774 cells was reverse transcribed using random hexamer primers. The resulting cDNA was PCR-ampli®ed with two Cbl-speci®c primers annealing immediately 5' of the RING ®nger region and the 3' end of Cbl spanning the Cbl stop-codon. Direct sequencing of the resulting PCR product revealed that the mutation in p95Cbl is based on an in-frame deletion of 333 bp in the coding region of Cbl.
Expression of p95Cbl transforms NIH3T3 fibroblasts in culture
Based on the nature of the deletion present in p95Cbl, which would cripple its ubiquitin ligase activity we hypothesized that it might be a transforming mutant of the Cbl proto-oncogene. Therefore, we stably expressed p95Cbl as well as c-Cbl in NIH3T3 ®broblasts by retroviral infection and monitored the cells for morphological changes. As shown in Figure  5 , NIH3T3 ®broblasts expressing p95Cbl attained the refractile morphology typical of transformed cells, while cells carrying the retroviral vector alone or the wildtype Cbl protein remained¯at and contact inhibited. Furthermore, NIH3T3 cells harboring the mutant Cbl allele displayed anchorage-independence when plated in soft agar, whereas c-Cbl and vector control cells did not grow under these conditions (Figure 5c ), in spite of the fact that the wildtype c-Cbl protein was considerably overexpressed compared to vector control cells (Figure 5b ). NIH3T3 ®broblast carrying an activated allele of the Src-family kinase Hck were used as a positive control for anchorageindependent growth. These data establish that p95Cbl c-Cbl p95Cbl is hyperphosphorylated in NIH3T3 cells and partitions into the particulate fraction 70Z Cbl is constitutively phosphorylated when expressed in NIH3T3 ®broblasts, which has been proposed to be the basis of its transforming capacity. Immunoprecipitation of p95Cbl from cell-free detergent lysate prepared from quiescent NIH3T3 cells revealed that p95Cbl was hyper-phosphorylated as well, while vector control or c-Cbl expressing cells did not show any distinct Cbl tyrosine phosphorylation (Figure 6a ). In addition, the background tyrosine phosphorylation of several proteins was enhanced in p95Cbl expressing cells compared to wildtype Cbl and vector control cells, particularly of one or more proteins of approximately 70 ± 75 kDa of unknown identity (Figure 6a ).
Since p95Cbl is constitutively associated with membranes in J-774 cells (Figure 1b) we hypothesized that this altered subcellular localization might be an intrinsic property that is unique to mutant p95Cbl and might be related to its transforming potential. In order to discern the subcellular localization of p95Cbl in ®broblasts, NIH3T3 cells expressing either vector alone, wildtype or p95Cbl cDNAs were fractionated by high-speed centrifugation and the Cbl proteins were immunoprecipitated from the individual fractions. p95Cbl partitions into both the cytosolic and particulate fractions, whereas wildtype c-Cbl is primarily present in the cytosol (Figure 6b) . Interestingly, the bulk of the mutant Cbl protein associated with membranes was constitutively tyrosine phosphorylated, while tyrosine phosphorylation of the cytosolic form was barely discernible.
Discussion
In this study we describe the cloning of a novel, naturally occurring c-Cbl mutant from the murine reticulum cell sarcoma, J-774. The 95 kDa mutant Cbl protein is the product of a deletion eliminating a sequence of 111 amino acids, which originates in the ahelical linker region and extends through the RING ®nger domain into the Cbl C-terminus, leaving the proline-rich region and the rest of the Cbl C-terminus intact. The p95Cbl deletion commences at the identical residue as in the 70Z Cbl mutant, which is caused by a splice acceptor site mutation and prompts the loss of 17 amino acids at the 5' boundary of an exon, rendering the protein oncogenic (Andoniou et al., 1994) . Both, the 70Z/3 B-cell lymphoma and the J-774 reticulum cell sarcoma cell line, were derived from mice that had been submitted to a tumor induction program consisting of treatment with the carcinogen methyl-nitrosourea (Paige et al., 1978) or mineral oil adjuvant injections (Cohn, 1967; Hirst et al., 1971; , respectively. It is conceivable that p95Cbl is the result of an aberrant splice event similar to the one giving rise to the 70Z Cbl protein and that the splice acceptor site aected denotes a hotspot for mutations in the murine Cbl sequence. Alternatively, p95Cbl could be the product of a genomic deletion, again arguing for the presence of a mutation-sensitive region within the cbl gene locus.
NIH3T3 ®broblasts stably expressing p95Cbl acquire a transformed phenotype and become anchorageindependent (Figure 5c ), but remain reliant on the presence of serum for growth, which is in concordance with what has been observed for the other known oncogenic Cbl proteins. Similar to what has been reported for the 70Z Cbl mutant (Andoniou et al., 1994) , p95Cbl is constitutively tyrosine phosphorylated when expressed in NIH3T3 cells. This is reminiscent of its consistent increase in background phosphorylation we have observed in J-774 cells and corresponds with the aberrant subcellular localization of the mutant Cbl protein in both hematopoietic cells and ®broblasts. In quiescent cells, c-Cbl is predominantly localized in the cytoplasm and relocalizes to the plasma membrane in response to cellular stimulation. There it associates with activated receptors and aids in the assembly and subsequent degradation of active signaling complexes through the recruitment of other cytoplasmic signaling molecules. The majority of p95Cbl is associated with membranes even in the absence of an external stimulus (Figures 1b and 6b) . It is possible that the inappropriately tyrosine-phosphorylated p95Cbl protein is constitutively associated with a cell-surface receptor or another signaling molecule at the plasma membrane where it promotes the assembly of speci®c signaling complexes, thus triggering the activation of signaling networks out of the context of an extracellular cue. This is corroborated by the observation that the presence of p95Cbl causes a general increase in cellular tyrosine phosphorylation levels in unstimulated cells (Figure 6a ). The signi®cance of aberrant Cbl tyrosine phosphorylation and subcellular localization in the progression of various neoplastic disorders is supported by data from Brizzi et al. (1998) reporting the constitutive tyrosine phosphorylation of c-Cbl in primary leukemic cells, which is concomitant with its relocalization to the detergent-insoluble fraction. The identity of the kinase responsible for the enhanced p95Cbl phosphorylation we observed in NIH3T3 cells has not been determined thus far. It is well established that c-Cbl is a downstream component of EGFR and PDGFR signal transduction pathways, where it mediates the attenuation of the signals through downregulation of the activated receptor complexes (Bonita et al., 1997; Levkowitz et al., 1996 Levkowitz et al., , 1998 Miyake et al., 1999) . However, treatment of the p95Cbl expressing murine ®broblasts with inhibitors speci®c for the EGF and PDGF receptors even for extended periods of time was not sucient to revert the phenotype of these cells, nor did it aect the tyrosine phosphorylation status of p95Cbl (data not shown). This suggests that p95Cbl exerts its transforming eect downstream of the receptor level and that enhanced p95Cbl phosphorylation is probably not an immediate eect of EGFR or PDGFR activity. Similarly, treatment of these cells with the general tyrosine kinase inhibitors herbimycin and genistein, and the Src-family selective inhibitors PP1 and PP2 did not have any discernible eects on either protein phosphorylation status or cellular transformation (data not shown). Cbl or vector control virus (pBabe). After selection in 2 mg/ml puromycin, pools of stable clones were lysed in 1% NP40 lysis buer. 50 mg of total extract or Cbl proteins immunoprecipitated from 350 mg cell extract were separated by SDS ± PAGE and detected by Western blot with the phosphotyrosine-speci®c mAb, 4G10. (b) Tyrosine phosphorylated p95
Cbl is constitutively associated with membranes in NIH3T3 cells. Following hypotonic lysis, NIH3T3 cells stably expressing the retroviral Cbl constructs or the vector alone were fractionated by high-speed centrifugation. Cbl proteins were immunoprecipitated from the cytosol (cy) and the particulate fraction enriched for membranes (m) after resuspension in 1% NP40 lysis buer, separated by SDS ± PAGE and visualized by Western blot with a-Cbl mAb (b, upper panel). The HRP was inactivated with 0.05% Na-azide and the above blot was reprobed with the phosphotyrosine-speci®c mAb, 4G10 (b, middle panel). As a loading control, 1/5 of the cytosolic and the particulate fractions were separated by SDS ± PAGE and detected by Western blot with an a-Pyruvate kinase pAb (b, lower panel) We propose that p95Cbl induces cellular transformation by two complementary mechanisms. While the entire RING ®nger and surrounding sequence required for Cbl's ubiquitin ligase activity are absent in the mutant p95Cbl protein thus abrogating its E3 ubiquitin ligase activity, most of its protein ± protein interaction domains remain intact. Therefore, phosphorylated p95Cbl would still be capable of acting as a scaold upon which signaling complexes are assembled, and might provide the foundation for the initiation of inappropriate signaling events. Its constitutive tyrosine phosphorylation in combination with its aberrant subcellular localization might further enhance p95Cbl's putative positive role on signal initiation and transduction. Secondly, p95Cbl might act in a dominant negative fashion and prevent access of wildtype c-Cbl to its substrates, thus interfering with the downregulation of already activated signaling pathways and leading to a prolonged signaling response. Furthermore, a positive regulatory role for Cbl in integrin-induced signaling events and the regulation of the actin-cytoskeleton, which requires PI(3) kinase activity and might be independent of the presence of a functional RING ®nger domain has been suggested (Meng and Lowell, 1998; Ojaniemi et al., 1998; Scaife and Langdon, 2000; Zell et al., 1998) and might explain how transforming mutants of c-Cbl could render cells anchorage-independent.
Like wildtype Cbl, the mutant p95Cbl protein expressed in J-774 cells is inducibly tyrosine phosphorylated in response to Fcg and CSF-1 receptor stimulation (Figure 3 and data not shown), thus arguing that p95Cbl is an active component of at least two signal transduction pathways that are critically important for normal hematopoietic cell function. As demonstrated by Sato et al. (1999) expression of v-Cbl and 70Z Cbl augments Fcg receptor mediated phagocytosis in P388D1 murine macrophage cells. It is conceivable that the presence of the 95 kDa Cbl mutant expressed in J-774 macrophages has similar enhancing eects on various cellular signaling pathways and data obtained from these cell lines should therefore be interpreted with caution.
The identi®cation of a third oncogenic form of Cbl from a cancer cell line suggests that alterations to Cbl might be a factor in the progression of a number of malignancies. Although all of the transforming alleles isolated thus far have been of murine origin, it is conceivable that mutations in Cbl will also prove to play an important role in human carcinogenesis. A truncated Cbl protein has been identi®ed in the human cutaneous T-cell lymphoma line, HUT78, which was caused by genetic rearrangements of the cbl locus (Blake and Langdon, 1992) . Although the HUT78 mutant protein is not oncogenic on its own, it might act as a contributing factor in the progression to cancer. The human c-cbl gene is located on the short arm of chromosome 11, a region which is frequently involved in rearrangements found in leukemias and lymphomas (Savage et al., 1991) . Moreover, the presence of distinct, smaller transcripts in addition to the 11 kb c-Cbl mRNA in various murine and human hematopoietic tumor cell lines (Langdon et al., 1989b) might further indicate that mutations in the cbl gene are more common in human tumors than currently appreciated and other, as of yet unidenti®ed Cbl mutants might be present in and contribute to a number of malignant states.
Materials and methods
Cloning of p95Cbl and generation of retroviral constructs 5 mg of total mRNA isolated from J-774 cells was reverse transcribed with random hexamer primers and the resulting cDNA was PCR ampli®ed using a primer annealing immediately 5' to the Cbl RING ®nger region (middleCblF: 5'-GATTGATGGCTTCAGGGAAGG-3') in combination with a primer spanning the Cbl-stop codon (3'-Cbl: 5'-CTCACGTAGCCACCTAGCACAATCT-3'). The 5' Cbl region was PCR ampli®ed from human c-Cbl cDNA (a kind gift of Dr WY Langdon, University of Western Australia, Crawley, Australia) with a 5' primer spanning the start codon (5'Xho-Cbl: 5'-CGCTCGAGCCGCCATGGCCGGCAACG-TGA-3') and a 3' primer complementary to the 5' primer used in the initial RT ± PCR reaction (middleCblR: 5'-CCTTCCC-TGAAGCCATCAATC-3'). A XhoI site in the primer sequence is underlined, the start-and stop-codons are indicated in bold script. The resulting 20 bp overlapping sequence in the 3' and 5' Cbl fragments were allowed to anneal and elongated using the Klenow-fragment of DNA polymerase I (GIBCO ± BRL, Canadian Life Technologies; Burlington, Ont, Canada), followed by PCR ampli®cation and cloning of the resulting full-length p95Cbl cDNA into the ecotropic retroviral expression vector pBabepuro3 (Morgenstern and Land, 1990) for expression in NIH3T3 cells. An activated allele of Hck (HckY501F) was constructed as described previously Howlett et al., 1999) and subcloned into pBabepuro3 for retroviral infection of NIH3T3 ®broblasts.
Cell culture and soft agar cloning
The hematopoietic J-774, Raw264.7, THP-1, U937 and murine bone marrow macrophage (BMMP) cell lines were maintained in RPMI 1640 supplemented with 10% heatinactivated fetal bovine serum (GIBCO ± BRL, Canadian Life Technologies; Burlington, Ont, Canada), 1 mM sodium pyruvate, 1% penicillin/streptomycin and 50 mM b-Mercaptoethanol, and with 10% L-cell conditioned medium for the BMMPs.
Murine ®broblast cell lines stably expressing the Cbl proteins were established after infection of NIH3T3 ®bro-blasts (clone 7) with replication-defective helper-free virus stocks of each cDNA construct as described previously for the retroviral LNCX vector . The C7-3T3 cell lines expressing the 120 kDa c-Cbl or the p95Cbl mutant as well as the vector control cells were maintained in Dulbecco's modi®ed Eagle minimal medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (GIBCO ± BRL, Canadian Life Technologies; Burlington, Ontario, Canada), 1% penicillin/streptomycin, and 2 mg/ml puromycin when under selection.
For soft agar assays, 1610 5 cells were seeded in phenol-red free DMEM containing 10% fetal bovine serum and 0.35% low-melting temperature (LMT) agarose. This suspension was sandwiched between two layers of DMEM containing 0.7% LMT agarose. After 15 days, live cells were stained overnight with MTT (0.1 mg/ml phenol-red free DMEM). Photomicrographs were taken at a magni®cation of 206 on an Olympus IX70 inverted microscope. Photographs were taken on a Nikon Cool Pix 995 digital camera.
Cell stimulations, preparations of lysates and subcellular fractionations J-774 and Raw264.7 cells were plated in 6-well plates and starved for 4 h in RPMI 1640 supplemented with 0.1% fetal bovine serum, followed by incubation with 2 mg/ml mouse IgG at 48C for 30 min. Cross-linking of Fcg receptors was achieved by addition of 2.4 mg/ml goat anti-mouse IgG F(ab') 2 (Pierce; Rockford, IL, USA) and incubation at 378C for the indicated times. Cells were rinsed once with Phosphate-buered saline (PBS, pH 7.4) and lysed in 1% Nonidet P-40 (NP40) lysis buer, composed of 50 mM HEPES (pH 7.5), 150 mM NaCl, 1.5 mM MgCl 2 , 1 mM ethylene-glycol-bis(b-aminoethyl ether)-N',N',N',N'-tetraacetic acid (EGTA), 10% glycerol, 1% NP40 (protein grade; Calbiochem; La Jolla, CA, USA), 1 mM PMSF (Boehringer Mannheim; Laval, PQ), 1 mM sodium orthovanadate, and 10 mg/ml of each aprotinin and leupeptin (Sigma). Insoluble material was removed by centrifugation at 12 000 g for 15 min at 48C. Prior to analysis total protein in the cell lysates was measured using a colorimetric BCA protein assay (Pierce; Rockford, IL, USA) against bovine serum albumin standards.
For crude membrane fractionations, cells were washed twice with Phosphate-buered saline (PBS), and once with hypotonic buer (10 mM Tris, pH 8.0, 10 mM KCl supplemented with 0.1% b-Mercaptoethanol, 1 mM sodium orthovanadate, 1 mM PMSF, and 10 mg/ml each of aprotinin and leupeptin) followed by incubation in hypotonic buer on ice for 20 min. The cells were disrupted by dounce homogenization and adjusted to 0.25 M sucrose, 1 mM EDTA and any leftover intact cells or nuclei were removed by centrifugation at 3000 g for 10 min. Supernatants were transferred to ultra centrifuge tubes and cytosol and crude particulate fractions enriched for membranes were prepared by centrifugation of the extracts at 100 000 g. The membrane-enriched pellet was solubilized in 1% NP40 lysis buer and the cytosolic fraction was adjusted to 1% NP40 and 150 mM NaCl. Immunoprecipitations were carried out as described below.
Immunoprecipitations and Western blotting
Cell-free lysates from stimulated or unstimulated cells were incubated with 5 mg/ml Cbl monoclonal antibody (7G10) for 1 h at 48C. Protein G-Sepharose was added and the mixtures were incubated for an additional 30 min at 48C. The immune-complexes were washed several times with 1% NP40 lysis buer and the samples were boiled in 26SDS Laemmli's sample buer prior to separation on 10% SDS polyacrylamide gels. Following electrophoresis, the proteins were transferred to nitrocellulose membranes (Schleicher & Schuell) . Membranes were dried and blocked in Tris-buered saline (5 mM Tris, 135 mM NaCl, 5 mM KCl) containing 0.5% NP40, 0.1% Tween-20 and 5% bovine serum albumin (BSA) for 4G10 blots, or 0.1% NP40, 0.1% Tween-20 and 5% skim milk for non-phosphotyrosine blots for 20 min. Membranes were then incubated for 1 h with a 1 : 1000 dilution of the appropriate antibodies in their respective blocking buers. The membranes were washed extensively in TBS containing 0.1% NP40 and 0.1% Tween-20, or 0.5% NP40 and 0.1% Tween-20 when a-phosphotyrosine antibody was used. This was followed by incubation for 20 min with either donkey a-rabbit horseradish-peroxidase (HRP) or sheep anti-mouse horseradish-peroxidase conjugates (Amersham; Arlington Heights, IL, USA), each diluted 1 : 10 000 in blocking buer. The membranes were washed as described above and developed using an enhanced chemiluminescence substrate (ECL; Amersham; Arlington Heights, IL, USA).
GST-fusion proteins, pulldown assays and Far Western blotting
The GST-Hck fusion proteins used were constructed and prepared as described previously (Howlett et al., 1999) . Puri®ed fusion proteins (30 mg) bound to Glutathione Stransferase (GST) agarose beads (Sigma) were added to cellfree detergent extracts prepared from J-774 and Raw264.7 cells and agitated at 48C for 2 h. The GST-beads were washed extensively in 1% NP40 lysis buer, boiled in 26SDS Laemmli sample buer and analysed by Western blotting.
For Far-Western analysis, Cbl-proteins were immunoprecipitated from J-774 and Raw264.7 detergent lysates, separated by SDS-polyacrylamide electrophoresis and transferred to nitrocellulose membranes as described above. The blots were blocked in Tris-buered saline and 0.05% Tween-20 (Sigma-Aldrich) (TBS-T) containing 3% BSA, followed by incubation with 5 mg/ml of the puri®ed GST-protein on its own or the puri®ed GST-Hck-unique/SH3/SH2 fusion protein in TBS-T/1% BSA for 2 h at 48C. The membranes were washed three times with TBS-T and the fusion proteins were detected with a polyclonal a-GST antibody as described above.
Antibodies
The polyclonal a-Cbl antibody (raised to residues 892 ± 906) was obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Rabbit polyclonal antibody to GST was made using puri®ed GST protein. The pyruvate kinase rabbit polyclonal antibody was a kind gift from AU Foster-Barber and JM Bishop (UCSF, San Francisco, CA, USA). The Cbl 7G10 monoclonal antibody raised against residues 878 ± 906 is available through Upstate Biotechnology (Lake Placid, NY, USA), a second monoclonal c-Cbl antibody raised to an epitope in the amino acid sequence 595 ± 810 was purchased from Transduction Labs (Lexington, KY, USA). The monoclonal phosphotyrosine antibody 4G10 was obtained from Upstate Biotechnology (Lake Placid, NY, USA).
In vitro translations
2 mg of total RNA isolated from J-774 and U937 cells was translated in rabbit reticulocyte lysate (Promega; Madison, WI, USA) according to the manufacturer's recommendations. The samples were diluted with 0.5 ml 1% NP40 lysis buer and Cbl proteins were immunoprecipitated from the reactions as described above.
